1. Al Sawah E, Marchion D, Xiong Y, Ramirez-Diaz I, Abbasi F, Bou Zgheib N, Hakam A, Wenham R, Lancaster J, Judson Lancaster P (2013) Molecular characterization of polyphyllin D, a Chinese herb that sensitizes ovarian cancers cells to platinum therapy. Gynecol Oncol 130:e131–e132
2. Angelini A, Di Ilio C, Castellani ML, Conti P, Cuccurullo F (2010) Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. J Biol Regul Homeost Agents 24:197–205
3. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul Pn (2002) Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64:573–582
4. Arienti C, Tesei A, Ravaioli A, Ratta M, Carloni S, Mangianti S, Ulivi P, Nicoletti S, Amadori D, Zoli W (2008) Activity of lipoplatin in tumor and in normal cells in vitro. Anticancer Drugs 19(983–990):9. doi: 10.1097/CAD.1090b1013e3283114fb3283112
5. Baumert C, Hilgeroth A (2009) Recent advances in the development of P-gp inhibitors. Anti-Cancer Agents Med Chem 9:415–436